Citations
A. Chalfin, et al. Overdose Prevention Centers, Crime, and Disorder in New York City. JAMA Network Open. Vol. 6. November 13, 2023, p. e2342228. doi: 10.1001/jamanetworkopen.2023.42228.
A. Irwin, et al. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility. Harm Reduction Journal. Vol. 14. May 12, 2017. doi: 10.1186/s12954-017-0153-2.
P.J. Davidson, et al. Impact of a high-volume overdose prevention site on social and drug disorder in surrounding areas in San Francisco. Drug and Alcohol Dependence. Vol. 252. November 1, 2023, p. 110969. doi: 10.1016/j.drugalcdep.2023.110969.
R.E. Giglio, et al. The Nation’s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City. Journal of Urban Health. Vol. 100. April 4, 2023, p. 245. doi: 10.1007/s11524-023-00717-y.
C. Potier, et al. Supervised injection services: what has been demonstrated? A systematic literature review. Drug and Alcohol Dependence. Vol. 145. December 1, 2014, p. 48. doi: 10.1016/j.drugalcdep.2014.10.012.
T.W. Levengood, et al. Supervised Injection Facilities as Harm Reduction: A Systematic Review. American Journal of Preventive Medicine. Vol. 61. November 1, 2021, p. 738. doi:10.1016/j.amepre.2021.04.017.
A.H. Bayoumi and G.S. Zaric. The cost-effectiveness of Vancouver’s supervised injection facility. CMAJ: Canadian Medical Association Journal. Vol. 179. November 18, 2018, p. 1143. doi:10.1503/cmaj.080808.
A. Harocopos, et al. First 2 Months of Operation at First Publicly Recognized Overdose Prevention Centers in US. JAMA Network Open. Vol. 5. July 15, 2022, p. e2222149. July 1, 2022, doi: 10.1001/jamanetworkopen.2022.22149.
A.H. Kral, et al. Evaluation of an Unsanctioned Safe Consumption Site in the United States. The New England Journal of Medicine. Vol. 383. August 6, 2020, p. 589. doi: 10.1056/NEJMc2015435.
P.J. Davidson, et al. Impact of an unsanctioned safe consumption site on criminal activity, 2010-2019. Drug and Alcohol Dependence. Vol. 220. March 1, 2021, p. 108521. doi: 10.1016/j.drugalcdep.2021.108521.
L.W. Suen, et al. Evaluating oxygen monitoring and administration during overdose responses at a sanctioned overdose prevention site in San Francisco, California: A mixed-methods study. The International Journal on Drug Policy. Vol. 121. November 1, 2023, p. 104165. doi: 10.1016/j.drugpo.2023.104165.
P.J. Davidson, et al. Establishment and Enforcement of Operational Rules at an Unsanctioned Safe Drug Consumption Site in the United States, 2014-2020. American Journal of Public Health. Vol. 112,S2. March 29, 2022. p.S166-S172. doi: 10.2105/AJPH.2022.306714.
E. Wood, et al. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. Vol. 102. May 22, 2007, p. 916-9. doi: 10.1111/j.1360-0443.2007.01818.x.
Department of Health and Human Services, National Institutes of Health and National Institute on Drug Abuse. “Overdose Prevention Centers.” https://nida.nih.gov/sites/default/files/NIH-RTC-Overdose-Prevention-Centers.pdf. Accessed January 8, 2024.
NYC Health. “Overdose Prevention in New York City: Supervised Injection as a Strategy to Reduce Opioid Overdose and Public Injection.” https://www.nyc.gov/assets/doh/downloads/pdf/public/supervised-injection-report.pdf. Accessed January 8, 2024.